Comment
doi: 10.1056/NEJMc1405715.
Spironolactone for heart failure with preserved ejection fraction
- PMID: 25006726
- DOI: 10.1056/NEJMc1405715
Item in Clipboard
Comment
Spironolactone for heart failure with preserved ejection fraction
N Engl J Med.
.
Free article
No abstract available
Comment on
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Apr 10;370(15):1383-92. doi: 10.1056/NEJMoa1313731. N Engl J Med. 2014. PMID: 24716680 Clinical Trial.
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):179. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006727 No abstract available.
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):179-80. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006728 No abstract available.
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):180. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006729 No abstract available.
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):181. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006730 No abstract available.
Similar articles
-
Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?Curr Atheroscler Rep. 2015 Nov;17(11):64. doi: 10.1007/s11883-015-0541-6. Curr Atheroscler Rep. 2015. PMID: 26408016 Review.
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):181. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006730 No abstract available.
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):180. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006729 No abstract available.
-
Spironolactone for heart failure with preserved ejection fraction.N Engl J Med. 2014 Jul 10;371(2):179-80. doi: 10.1056/NEJMc1405715. N Engl J Med. 2014. PMID: 25006728 No abstract available.
-
Effect of Mineralocorticoid Receptor Antagonists in Individuals With Heart Failure With Preserved Ejection Fraction: A Systematic Review.J Card Fail. 2018 Sep;24(9):618-621. doi: 10.1016/j.cardfail.2018.08.006. Epub 2018 Sep 5. J Card Fail. 2018. PMID: 30194985 No abstract available.
Cited by
-
Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.Acta Pharmacol Sin. 2023 Jun;44(6):1149-1160. doi: 10.1038/s41401-022-01025-y. Epub 2022 Dec 6. Acta Pharmacol Sin. 2023. PMID: 36473990 Free PMC article.
-
Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?Curr Atheroscler Rep. 2015 Nov;17(11):64. doi: 10.1007/s11883-015-0541-6. Curr Atheroscler Rep. 2015. PMID: 26408016 Review.
-
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.Cochrane Database Syst Rev. 2020 Oct 27;10(10):CD007004. doi: 10.1002/14651858.CD007004.pub4. Cochrane Database Syst Rev. 2020. PMID: 33107592 Free PMC article.
-
Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target.Front Cardiovasc Med. 2022 May 6;9:886553. doi: 10.3389/fcvm.2022.886553. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35600469 Free PMC article. Review.
-
Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fraction.JCI Insight. 2018 Feb 22;3(4):e96006. doi: 10.1172/jci.insight.96006. eCollection 2018 Feb 22. JCI Insight. 2018. PMID: 29467337 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
